EOJOAM
PACB icon

E. Ohman J:or Asset Management’s Pacific Biosciences PACB Stock Holding History

E. Ohman J:or Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,476
Closed -$132K – 427
2023
Q4 		$132K Sell
13,476
-9,724
-42% -$79.5K ﹤0.01% 406
2023
Q3 		$194K Buy
23,200
+1,800
+8% +$20.6K 0.01% 407
2023
Q2 		$285K Buy
+21,400
New +$260K 0.01% 410

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

E. Ohman J:or Asset Management's PACB Position: Q1 2024 in Review

E. Ohman J:or Asset Management sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 13,476 shares — an estimated $132K sold.

E. Ohman J:or Asset Management first reported a position in PACB in Q2 2023 and held it in 3 quarters. The position peaked at $285K in Q2 2023. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • E. Ohman J:or Asset Management reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • E. Ohman J:or Asset Management sold 13,476 Pacific Biosciences shares in Q1 2024, an estimated $132K.
  • E. Ohman J:or Asset Management first reported a position in Pacific Biosciences in Q2 2023 and held it in 3 quarters.
  • E. Ohman J:or Asset Management's Pacific Biosciences position peaked at $285K in Q2 2023.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on E. Ohman J:or Asset Management's 13F filing for Q1 2024, filed 14 May 2024.